Low high-density lipoprotein cholesterol: current status and future strategies for management
Open Access
- 1 October 2010
- journal article
- review article
- Published by Taylor & Francis in Vascular Health and Risk Management
- Vol. 6, 979-96
- https://doi.org/10.2147/VHRM.S5685
Abstract
Peer reviewed article authored by (Vibhuti Singh, Rakesh Sharma, Ajoy Kumar, et al). Read article or submit your manuscript for publishing.Keywords
This publication has 64 references indexed in Scilit:
- Low High-Density Lipoprotein Cholesterol and Increased Cardiovascular Disease Risk: An Analysis of Statin Clinical TrialsThe American Journal of Cardiology, 2009
- Standards of Medical Care in Diabetes—2008Diabetes Care, 2008
- Can novel Apo A-I polymorphisms be responsible for low HDL in South Asian immigrants?Indian Journal of Human Genetics, 2008
- Novel Peroxisome Proliferator Activated Receptor–α AgonistsThe American Journal of Cardiology, 2007
- Liver X Receptor and Farnesoid X Receptor as Therapeutic TargetsThe American Journal of Cardiology, 2007
- Illuminating HDL — Is It Still a Viable Therapeutic Target?New England Journal of Medicine, 2007
- Expert Commentary: The Safety of Fibrates in Lipid-Lowering TherapyThe American Journal of Cardiology, 2007
- Partial Inhibition of Platelet Thromboxane A2 Synthesis by Aspirin Is Associated With Myonecrosis in Patients With ST-Segment Elevation Myocardial InfarctionThe American Journal of Cardiology, 2007
- Safety Considerations with Niacin TherapyPublished by Elsevier ,2006
- Safety and compliance with once-daily niacin extended-release/lovastatin as initial therapy in the Impact of Medical Subspecialty on Patient Compliance to Treatment (IMPACT) studyThe American Journal of Cardiology, 2004